Market Cap
$24.0B
PHG
KONINKLIJKE PHILIPS NV
$23.88 ▲ +0.27%
Prev close $23.81Market cap$24.0B
ConsensusHold
12-mo target$32.13 (+34.6%)
▲ Neutral
Analyst conviction 5/10
High Impact Filing (8/10)23 New Institutional Positions18 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on PHG right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Buy (52%)
Inst. Holders
50 funds
Inst. Value
$865.0M
Inst. Activity
23 buys / 18 sells
SEC Reports
5
Press Releases
4
Price chart 30d -9.5%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 16, 2026 other
Aug 27, 2026 Press Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation
September 16, 2026
Philips and Imricor announced the first commercially available Interventional MR (iMR) lab solution combining Philips' 1
Impact 3/10
Philips priced EUR 650M in 4.0% fixed-rate notes due 2034 under its EMTN program, the healthcare industry's first EU Gre
Impact 3/10
Royal Philips reported Q2 2026 comparable sales growth of 4% to EUR 4.4B, with Adjusted EBITA margin expanding to 16.4%
PRESS-RELEASE — Impact 6/10
The Judicial Panel on Multidistrict Litigation issued Conditional Transfer Order (CTO-117) transferring one additional p
COURT-RULING — Impact 1/10
A single tag-along product liability case (Sexton v. Philips RS North America, LLC) was transferred to the existing Phil
COURT-RULING — Impact 2/10
Jun 30, 2026 Inst.
BlackRock, Inc. — ADD
1,995,282 shares ($54.3M)
Jun 30, 2026 Inst.
UBS Group AG — ADD
686,075 shares ($18.7M)
Analyst ratings buy % +13.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
52% rate it Buy or better · 29 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 3, 2026 | UBS | DOWNGRADE | Neutral | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 7 | 8 | 14 | 0 | 0 | 52% | |
| Aug 1, 2026 | 7 | 9 | 13 | 0 | 0 | 55% | |
| Jul 1, 2026 | 6 | 10 | 13 | 0 | 0 | 55% | |
| Jun 1, 2026 | 6 | 10 | 13 | 0 | 0 | 55% | |
| May 1, 2026 | 6 | 11 | 13 | 0 | 0 | 57% | |
| Apr 1, 2026 | 6 | 10 | 14 | 0 | 0 | 53% | |
| Mar 1, 2026 | 6 | 11 | 13 | 0 | 0 | 57% | |
| Feb 1, 2026 | 5 | 10 | 15 | 0 | 0 | 50% |
Price targets
Where 5 covering analysts think PHG trades over the next 12 months.
$32.13 +34.6% upside Strong Buy
Current$23.88 Low$26.75 Median$29.50 High$41.00 5 analysts
$26.75$41.00
Analyst rating Hold· 2.6/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
5 SEC filing reports analyzed · 2 bullish, 0 bearish, 1 mixed, 2 neutral · avg impact 4.2/10.Plus 4 press releases.
MIXEDPRESS-RELEASE6/10
Royal Philips reported Q2 2026 comparable sales growth of 4% to EUR 4.4B, with Adjusted EBITA margin
Jul 27, 2026
NEUTRALCOURT-RULING1/10
The Judicial Panel on Multidistrict Litigation issued Conditional Transfer Order (CTO-117) transferr
Jul 3, 2026
NEUTRALCOURT-RULING2/10
A single tag-along product liability case (Sexton v. Philips RS North America, LLC) was transferred
Jul 3, 2026
BULLISHCOURT-RULING4/10
The Fifth Circuit affirmed the district court's spoliation sanctions and damages award in favor of P
May 16, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 16, 2026
other
Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation
September 16, 2026
Sep 3, 2026
other
Philips advances women’s health ultrasound with new single-transducer solution
Philips introduces the eV14-2v, a single lightweight transducer designed to support gynecology and early obstetrics exams.
Aug 27, 2026
contract
Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration
August 27, 2026
Aug 26, 2026
contract
Philips selected for ARPA-H program to advance AI-enabled robotic stroke care
Philips receives up to US$33.7M from ARPA-H to develop AI-enabled robotics for remote, increasingly automated endovascular stroke care.
Aug 24, 2026
announcement
Philips prices EU green bond for EUR 650M
August 24, 2026
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.36 | $0.36–$0.36 | -13.0% | -12.8% | 0↑ 1↓ | $4.4B | 1 |
| Next Q | $0.64 | $0.64–$0.64 | -10.3% | +13.4% | 1↑ 0↓ | $5.3B | 1 |
| Current FY | $1.75 | $1.63–$1.92 | -5.5% | -0.4% | 3↑ 1↓ | $17.9B | 4 |
| Next FY | $1.90 | $1.75–$2.12 | 8.2% | -0.2% | 0↑ 4↓ | $18.7B | 4 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.360 | — |
| 7d ago | $0.400 | -0.040 |
| 30d ago | $0.413 | -0.053 |
| 60d ago | $0.413 | -0.053 |
| 90d ago | $0.402 | -0.042 |
Institutional ownership
Which big funds own PHG (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $865.0M total value (31,813,001 shares) as of 2026-Q2. Top holders: DIMENSIONAL, CAUSEWAY, MORGAN. Net buying activity: 23 institutions added/increased vs 18 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | 4,340,691 | $118.0M | 13.6% | — |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 3,061,962 | $83.3M | 9.6% | — |
| MORGAN STANLEY | 2,935,662 | $79.8M | 9.2% | — |
| FMR LLC | 2,654,029 | $72.2M | 8.3% | — |
| BRANDES INVESTMENT PARTNERS, LP | 2,210,252 | $60.1M | 6.9% | — |
| NORTHERN TRUST CORP | 2,085,496 | $56.7M | 6.6% | — |
| BlackRock, Inc. | 1,995,282 | $54.3M | 6.3% | ADD +36.9% |
| ENVESTNET ASSET MANAGEMENT INC | 1,297,945 | $35.3M | 4.1% | — |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 944,311 | $25.7M | 3.0% | DOUBLED +587.8% |
| GOLDMAN SACHS GROUP INC | 911,845 | $24.8M | 2.9% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | ADD | 1,457,550 | 1,995,282 | +36.9% | $54.3M |
| UBS Group AG | ADD | 533,794 | 686,075 | +28.5% | $18.7M |
| Quantinno Capital Management LP | ADD | 392,219 | 575,645 | +46.8% | $15.7M |
| Connor, Clark & Lunn Investment Management Ltd. | DOUBLED | 21,211 | 563,724 | +2557.7% | $15.3M |
| JANE STREET GROUP, LLC | DOUBLED | 130,461 | 264,491 | +102.7% | $7.2M |
| Optiver Holding B.V. | DOUBLED | 15,688 | 192,113 | +1124.6% | $5.2M |
| CITADEL ADVISORS LLC | TRIM | 238,141 | 154,777 | -35.0% | $4.2M |
| STIFEL FINANCIAL CORP | TRIM | 209,549 | 145,031 | -30.8% | $3.9M |
| BANK OF MONTREAL /CAN/ | ADD | 69,115 | 136,344 | +97.3% | $3.7M |
| LPL Financial LLC | TRIM | 179,671 | 129,164 | -28.1% | $3.5M |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for PHG.
Shares short
2,597,201
Settlement Sep 15, 2026
Change vs prior
+9.1%
Semi-monthly cycle
Days to cover
3.4
At avg daily volume
Of shares outstanding
≈0.3%
Estimate — not % of float
| Halted | Code | Reason | Status |
|---|---|---|---|
| Jul 27, 2026 | T1 | News Pending | Not resumed |
| Jul 27, 2026 | T3 | Resumption Scheduled | Resumed |
All PHG filing & press-release reports (9)
- PRESS-RELEASE reportAug 27, 2026
- PRESS-RELEASE reportAug 24, 2026
- PRESS-RELEASE reportJul 27, 2026
- COURT-RULING reportJul 3, 2026
- COURT-RULING reportJul 3, 2026
- PRESS-RELEASE reportJun 2, 2026
- COURT-RULING reportMay 16, 2026
- PRESS-RELEASE reportMay 6, 2026
- PRESS-RELEASE reportMar 23, 2026